RecruitingNot applicableNCT02641145
Molecular Imaging of Primary Amyloid Cardiomyopathy
Studying Primary systemic amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brigham and Women's Hospital
- Principal Investigator
- Sharmila Dorbala, MD, M.DBrigham and Women's Hospital (AHA and NIH Studies)
- Intervention
- F-18 florbetapir/C-11 acetate PET(radiation)
- Enrollment
- 171 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2016 – 2028
Study locations (1)
- Brigham and Womens' Hospital, Boston, Massachusetts, United States
Collaborators
National Institutes of Health (NIH) · National Heart, Lung, and Blood Institute (NHLBI) · American Heart Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02641145 on ClinicalTrials.govOther trials for Primary systemic amyloidosis
Additional recruiting or active studies for the same condition.